Clinical Trials Directory

Trials / Completed

CompletedNCT00942669

Comparing the Sleep Strip OTC™ Accuracy in Screening for Sleep Apnea Syndrome Against the Reference Method, an In-lab Full Night Polysomnographic (PSG)

A Prospective, Single Center, Open, Equivalence, Two Phase Study Comparing the Sleep Strip OTC™ Accuracy in Screening for Sleep Apnea Syndrome Against the Reference Method, an In-lab Full Night Polysomnographic (PSG) Study.

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Scientific Laboratory Products, Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of this study is to demonstrate the equivalence of the new Sleep Strip OTC(TM) compared to the reference method of an in-lab, attended full-night polysomnographic (PSG) study.

Detailed description

A prospective, single center two phase study to evaluate the validity and the predictability of the SleepStrip OTCTM in screening for SAS, as compared to the reference method, an in-lab, full night, attended Polysomnographic (PSG) Study. The study will consist of two phases: I: Optimization Phase:will be performed at the Clinic; 20 participants will be enrolled. Each participant will be connected simultaneously to the SleepStrip OTC(TM) and to the standard lab sensors and recorder. This phase is intended to allow SLP to optimize the analysis parameters for optimal performance and will be considered as a pilot phase. II: Equivalence phase: At least 180 participants will be enrolled. All participants will receive the SleepStrip OTC(TM) for a night test at home, before or after undergoing an independent PSG test at the Sleep lab. Out of 180 participants, at least 26 participants will receive two SleepStrip OTC(TM) devices for two consecutive night tests at home. The remaining participants will receive one SleepStrip OTC(TM) for one night test.

Conditions

Interventions

TypeNameDescription
DEVICESleepStrip OTC(TM)self contained SAS screening device

Timeline

Start date
2009-08-01
Primary completion
2011-11-01
Completion
2012-02-01
First posted
2009-07-21
Last updated
2012-06-07

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00942669. Inclusion in this directory is not an endorsement.